α-Synuclein aggregation in the saliva of familial transthyretin amyloidosis: a potential biomarker

References

• Benson, MD. The molecular basis of inherited disease, amyloidosis. Vol III, 7th ed. New York: McGraw-Hill; 1995. pp 4159.
   Google Scholar
• Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 2003;10:160–184.
   PubMed Web of Science ®Google Scholar
• Saraiva MJ, Costa PP, Goodman DS. Studies on plasma transthyretin (prealbumin) in familial amyloidotic polyneuropathy, Portuguese type. J Lab Clin Med 1983;102:590–603.
   PubMed Web of Science ®Google Scholar
• Saraiva MJ, Costa PP, Goodman DS. Biochemical marker in familial amyloidotic polyneuropathy, Portuguese type. Family studies on the transthyretin (prealbumin)-methionine-30 variant. J Clin Invest 1985;76:2171–2177.
   PubMed Web of Science ®Google Scholar
• Kelly JW, Colon W, Lai Z, Lashuel HA, McCulloch J, McCutchen SL, Miroy GJ, Peterson SA. Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid. Adv Protein Chem 1997;50:161–181.
   PubMedGoogle Scholar
• Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952;75:408–427.
   PubMed Web of Science ®Google Scholar
• Saraiva MJ, Birken S, Costa PP, Goodman DS. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest 1984;74:104–119.
   PubMed Web of Science ®Google Scholar
• Lewis WD, Skinner M, Simms RW, Jones LA, Cohen AS, Jenkins RL. Orthotopic liver transplantation for familial amyloidotic polyneuropathy. Clin Transplant 1994;8:107–110.
   PubMed Web of Science ®Google Scholar
• Conceição IM, Castro JF, Scotto M, de Carvalho M. Neurophysiological markers in familial amyloid polyneuropathy patients: early changes. Clin Neurophysiol 2008;119:1082–1087.
   PubMed Web of Science ®Google Scholar
• Devic I, Hwang H, Edgar JS, Izutsu K, Presland R, Pan C, Goodlett DR, et al. Salivary a-synuclein and DJ-1: potential biomarkers for Parkinson’s disease. Brain 2011;134:e178.
   PubMed Web of Science ®Google Scholar
• Rosenfeld J, Capdevielle J, Guillemot JC, Ferrara P. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal Biochem 1992;203:173–179.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Lee SJ. Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. J Biol Chem 2002;277:48976–48983.
   PubMed Web of Science ®Google Scholar
• Giasson BI, Uryu K, Trojanowski JQ, Lee VM. Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem 1999;274:7619–7622.
   PubMed Web of Science ®Google Scholar
• Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993;341:1113–1116.
   PubMed Web of Science ®Google Scholar
• Ericzon BG, Larsson M, Herlenius G, Wilczek HE; Familial Amyloidotic Polyneuropathy World Transplant Registry. Report from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR) and the Domino Liver Transplant Registry (DLTR). Amyloid 2003;10 Suppl 1:67–76.
   PubMed Web of Science ®Google Scholar
• Monteiro E, Freire A, Barroso E. Familial amyloid polyneuropathy and liver transplantation. J Hepatol 2004;41:188–194.
   PubMed Web of Science ®Google Scholar
• Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa PM, Feray C, Planté V, et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000;123 (Pt 7):1495–1504.
   PubMed Web of Science ®Google Scholar
• Tashima K, Ando Y, Terazaki H, Yoshimatsu S, Suhr OB, Obayashi K, Yamashita T, et al. Outcome of liver transplantation for transthyretin amyloidosis: follow-up of Japanese familial amyloidotic polyneuropathy patients. J Neurol Sci 1999;171:19–23.
   PubMed Web of Science ®Google Scholar
• de Carvalho M, Conceição I, Bentes C, Luís ML. Long-term quantitative evaluation of liver transplantation in familial amyloid polyneuropathy (Portuguese V30M). Amyloid 2002;9:126–133.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Wilczek HE, Nowak G, Larsson M, Oksanen A, Iwata T, Gjertsen H, et al. Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years. Am J Transplant 2007;7:2597–2604.
   PubMed Web of Science ®Google Scholar
• da Costa G, Gomes R, Correia CF, Freire A, Monteiro E, Martins A, Barroso E, et al. Identification and quantitative analysis of human transthyretin variants in human serum by Fourier transform ion-cyclotron resonance mass spectrometry. Amyloid 2009;16:201–207.
   PubMed Web of Science ®Google Scholar
• El-Agnaf OM, Salem SA, Paleologou KE, Curran MD, Gibson MJ, Court JA, Schlossmacher MG, Allsop D. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson’s disease. FASEB J 2006;20:419–425.
   PubMed Web of Science ®Google Scholar
• Tokuda T, Qureshi MM, Ardah MT, Varghese S, Shehab SA, Kasai T, Ishigami N, et al. Detection of elevated levels of a-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 2010;75:1766–1772.
   PubMed Web of Science ®Google Scholar
• Ballard CG, Jones EL. CSF a-synuclein as a diagnostic biomarker for Parkinson disease and related dementias. Neurology 2010;75:1760–1761.
   PubMed Web of Science ®Google Scholar